AIIMS to start recruitment for Covaxin trial on kids from today

Tribune News Service

New Delhi, June 14

A day after the India taskforce of the Lancet Covid-19 Commission urged prioritisation of vaccinations in children with co-morbid conditions, AIIMS, New Delhi, said it would start recruiting children for Covaxin trials.

CISF to guard Covaxin facility at hyderabad

New Delhi: The CISF has taken over the security of vaccine manufacturer Bharat Biotech’s manufacturing facility in Hyderabad. A decision in this regard was taken by the Union Ministry of Home Affairs (MHA) last week with an aim to protect it against any terror threat or sabotage that may lead to a biological disaster. TNS

Monuments, museums to reopen tomorrow

Kolkata: All Centrally protected monuments, sites and museums will be reopened on Wednesday, the Archaeological Survey of India (ASI) said on Monday. Monuments and museums and sites protected by the ASI were closed on April 15 due to the second wave of the Covid-19 pandemic. TNS

The AIIMS team has completed initial screening of potential recruits for the vaccine trials in Indian children. The top Indian paediatricians in their research published on behalf of the Lancet Commission have recommended “urgent prioritisation for vaccination among at-risk kids”.

“As of June 11, India had administered 24.6 million doses of vaccines and we applaud the judicious approval of Covaxin clinical trials (Phase II/III) in children of 2 to 18 years,” said the experts.

The USA and the UK have already initiated vaccination in their respective populations.

The US has vaccinated more than 6.5 million adolescents between 12-17 years with at least one dose and about 3 million with both doses.

Join Whatsapp Channel of The Tribune for latest updates.